Company profile
Vitarka Therapeutics Ltd
Vitarka Therapeutics Ltd is a UK company with status active founded in 2021 based in South East England.
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQzMjY0OTA2N2FkaXF6a2N4
Published 19 Aug 2024 16:34
Company registered at Companies House
1 Jul 2023 to 31 Dec 2024
A new wave of RNA-therapeutics has the potential to transform outcomes for patients with cancers which do not respond to existing small molecule or antibody treatments. RNA-therapeutics have come to the forefront on the back of Covid vaccine success, and many Biotechs are now developing these for currently non-responding patient groups. This £6Bn potentia...
1 Apr 2023 to 30 Sep 2024
A new wave of RNA-therapeutics has the potential to transform outcomes for patients with cancers which do not respond to existing small molecule or antibody treatments. RNA-therapeutics have come to the forefront on the back of Covid vaccine success, and many Biotechs are now developing these for currently non-responding patient groups. This £6Bn potentia...
1 Nov 2022 to 28 Feb 2023
Vitarka is developing a new tumour-targeted intracellular delivery technology for nucleic-acid therapies. Our project supports the UK life science strategy and the UK's industrial strategy to grow the bioeconomy and help patients. Existing intracellular delivery systems for nucleic-acid therapies predominantly depend on viral methods. These are toxic and ...
